Evidence map›Paper›PMID 31068572›Full record

ReviewCell death & disease2019

The role of extracellular vesicles in renal fibrosis.

H Jing, S Tang, S Lin, M Liao, H Chen, J Zhou

Open access · goldAbstract readReview
In one paragraph

Review in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Nanoparticles in the Treatment of Renal Fibrosis.International journal of nanomedicine · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Extracellular Vesicles as Source of Biomarkers in Glomerulonephritis.International journal of molecular sciences · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

H JingZhuhai Campus of Zunyi Medical University, The first People's Hospital of Foshan, Golden Coast, Jinwan District, Zhuhai City, Guangdong Province, China.
S TangThe first People's Hospital of Foshan, 81 Lingnan Avenue, Chancheng District, Foshan City, Guangdong Province, China.
S LinThe first People's Hospital of Foshan, 81 Lingnan Avenue, Chancheng District, Foshan City, Guangdong Province, China.
M LiaoThe first People's Hospital of Foshan, 81 Lingnan Avenue, Chancheng District, Foshan City, Guangdong Province, China.
H ChenThe first People's Hospital of Foshan, 81 Lingnan Avenue, Chancheng District, Foshan City, Guangdong Province, China.
J ZhouThe first People's Hospital of Foshan, 81 Lingnan Avenue, Chancheng District, Foshan City, Guangdong Province, China. zhoujun7843@126.com.ORCID http://orcid.org/0000-0003-1545-8092
First People's Hospital of Foshan · CNZunyi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a particularly important mediator of intercellular communication, extracellular vesicles (EVs) have been proved to be extensively involved in various system diseases over the past two decades, including in renal diseases. As is well-known, renal fibrosis is the common pathological process of any ongoing renal disease or adaptive repair of kidney injury based on current knowledge. Although much work has been performed focusing on EVs in various renal diseases, the role of EVs in renal fibrosis has not been described in detail and summarized. In this review, we provide a brief overview of the definition, classification and biological process of EVs. Then, the potential mechanisms of EVs in renal fibrosis are illustrated. Lastly, recent advances in EVs and the implications of EVs for diagnosis and therapy in renal fibrosis disease are introduced. We look forward to a more comprehensive understanding of EVs in renal fibrosis, which could be a boon to patients with renal fibrosis disease.

Indexed as

BiomarkersExtracellular VesiclesFibrosisHumansKidney DiseasesMicroRNAsSignal TransductionTransforming Growth Factor betaBiomarkersMicroRNAsTransforming Growth Factor beta

Identifiers

PMID31068572
PMCPMC6506498
OpenAlexW2944278743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.